What Researchers Did
Researchers reported on a case where hyperbaric oxygen therapy successfully treated a 63-year-old woman with severe livedoid vasculopathy that had not responded to other treatments.
What They Found
A 63-year-old female patient with refractory livedoid vasculopathy, also having an MTHFR gene polymorphism, received hyperbaric oxygen therapy at 2.0 absolute atmosphere for 120 minutes, three times a week. After 4 sessions, her painful ulcers began to heal, and after 13 sessions, the skin lesions were almost completely healed. During an eight-month follow-up, the ulcers did not recur, and her symptoms remained stable.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This study is a single case report, which means its findings may not apply to all patients with livedoid vasculopathy.